NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

HIV seroprevalence among high and low risk women in Costa Rica, 1997.

Monge E, Ma LL, Moraga MM; International Conference on AIDS.

Int Conf AIDS. 1998; 12: 1060 (abstract no. 60332).

De Pto. AIDS Control, Ministry of Health, San Jose, Costa Rica.

OBJECTIVE: To determine the HIV seroprevalence among high and low risk women in Costa Rica. METHODS: Low risk women: Sentinel Study-anonymous and unliked. Samples: Group A: 800 pregnant women from Carit's Maternity Hospital in San Jose (Capital), April 1997. Group B: 800 pregnant women from Dr. Tony Facio Hospital in Limon (Caribbean Coast), June 1997. High risk women: Group C: AIDS and STD Program is the encharge of control and care of sexual workers. They assist each 15 days for control. The HIV test is voluntary and they ask for it each three months. Analysis of 1995 serological studies for HIV among sexual workers women attended during 1997. The tests used were EIA and Western blot. RESULTS: Group A and B had a prevalence of 0.25% and 0.13%, respectively. Group c had a prevalence of 0.25%. CONCLUSIONS: The seroprevalence is low (less than 1%). This situation must maintain; in consecuence, is necessary continue with the preventive programs for detection and treatment of Sexually Transmitted Infections and to promote specific interventions for women, taking in mind their specific needs.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • Caribbean Region
  • Costa Rica
  • Female
  • HIV Infections
  • HIV Seropositivity
  • HIV Seroprevalence
  • Humans
  • Pregnancy
  • Prevalence
  • Seroepidemiologic Studies
Other ID:
  • 98408581
UI: 102232283

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov